The same medications and treatments are not universally effective for every patient. As consumer knowledge of genetics increases, more patients will be coming to you with a direct-to-consumer (DTC) genetics test in hand. What expectations will your patients have? How does Pharmacogenomics (PGx) data help us determine which medication will work better for a specific patient? This course will answer those questions by framing PGx from the perspective of the patient.
Sign in to take quiz and track your certificates
AMA Pharmacogenomics Summit Series Education helps prescribers stay up to date on the emerging field of pharmacogenomics. Discover best practices from leading experts on pharmacogenomics-based selection, dosing and monitoring of medications to improve health outcomes. Learn more.
Module not playing? Click here
AMA CME Accreditation Information
Credit Designation Statement: The American Medical Association designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships.
If applicable, all relevant financial relationships have been mitigated.
Credit Designation Statement: The American Medical Association designates this Enduring Material activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
or
You currently have no searches saved.
You currently have no courses saved.